EICHOR

Recruiting studies: Tetanus Vaccine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
Phase 4 · 1 location(s) · Women and Infants Hospital of Rhode Island · NCT06135636 Post Marketing Surveillance Study for MenQuadfi® [Meningococcal (Groups A, C, Y, W) Polysaccharide Tetanus Toxoid Conjug
Phase N/A · 9 location(s) · Sanofi · NCT07621653 A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
Phase 1/Phase 2 · 1 location(s) · GC Biopharma Corp · NCT06997627 Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial
NA · 4 location(s) · Universiti Putra Malaysia · NCT06815250 A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
Phase N/A · 4 location(s) · Zhuhai Trinomab Pharmaceutical Co., Ltd. · NCT07107932 Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants
Phase 3 · 1 location(s) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · NCT06344065 Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
Phase 3 · 1 location(s) · Changchun BCHT Biotechnology Co. · NCT07112144 A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTp
Phase 3 · 18 location(s) · GlaxoSmithKline · NCT07596199 A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalen
Phase 2/Phase 3 · 1 location(s) · LG Chem · NCT06947499 Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy
Phase 4 · 4 location(s) · Canadian Immunization Research Network · NCT07097012 A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following In
Phase N/A · 1 location(s) · Zhuhai Trinomab Pharmaceutical Co., Ltd. · NCT07347938 Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
NA · 1 location(s) · Jiangsu Province Centers for Disease Control and Prevention · NCT06605755 Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135
Phase 1 · 1 location(s) · CanSino Biologics Inc. · NCT07203755 A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR20
Phase 3 · 20 location(s) · Genrix (Shanghai) Biopharmaceutical Co., Ltd. · NCT06635798 A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTp
Phase 3 · 10 location(s) · GlaxoSmithKline · NCT07596173 Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
Phase 1 · 3 location(s) · Institute of Medical Biology, Chinese Academy of Medical Sci · NCT06184542 Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910 Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children
Phase 2 · 1 location(s) · International Vaccine Institute · NCT07509047 Tetanus Severity Score for Prediction of Mortality in Manifest Tetanus
Phase N/A · 1 location(s) · Ain Shams University · NCT07512167

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →